Danaher Corporation vs Modine Manufacturing Company — how do they compare? Danaher Corporation trades at $219.41 (market cap $152.87B), while Modine Manufacturing Company trades at $182.11 (market cap $9.66B). The key difference: Danaher Corporation is far larger — about 15.8× Modine Manufacturing Company's market cap, and Danaher Corporation pays a 0.74% dividend while Modine Manufacturing Company pays none. Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and Modine Manufacturing Company for 33 Days on average.
| DHR | MOD | |
|---|---|---|
Market Cap | $152.87B | $9.66B |
Volume | 5,228,698 | 1,331,946 |
Sector | Health | Industrials |
52-Week High | $242.05 | $283.95 |
52-Week Low | $161.91 | $110.73 |
Typical Hold Time | 69 Days | 33 Days |
Enterprise Value | $175.08B | $10.09B |
Dividend Yield | 0.74% | — |
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $218.49, up 1.36% on the day, with a bullish technical signal and consistent earnings beats in recent quarters. The stock shows strong profitability with a 58.51% gross margin and 15.95% net income margin, though revenue growth has been modest. Analyst consensus is strongly bullish with a $230.31 price target, supported by institutional buying activity and a recent dividend announcement.
The outlook for DHR is positive, driven by earnings momentum and institutional confidence, but risks include elevated valuation multiples and competitive pressures in the healthcare sector. Investors should weigh the strong analyst support against potential margin compression and macroeconomic headwinds affecting capital spending.
Modine Manufacturing (MOD) trades at $182.00, down 3.93% on the day, amid a bearish technical signal and recent volatility following the completion of its Performance Technologies spin-off and merger with Gentherm. The company has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $1.53 surpassing the $1.30 expectation. Analyst sentiment remains strongly positive with a consensus price target of $331.25, though technical indicators show selling pressure with key support at $177 and resistance at $187.
The outlook is mixed; strong analyst support and recent strategic moves like the spin-off suggest long-term growth potential, but near-term risks include integration challenges, a high P/E ratio of 67.87, and a projected decline in net profit margin for 2026. Investors should weigh solid fundamentals against current technical weakness and execution risks.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →Modine Manufacturing Company is a global leader in thermal management technology and solutions. The company engineers, manufactures, and markets heat transfer products for a wide range of applications across the automotive, commercial, industrial, and HVAC (heating, ventilation, and air conditioning) markets. Modine's products include engine cooling systems, heat exchangers, and ventilation systems, providing critical thermal solutions for vehicles, data centers, and various equipment worldwide.
Read more on MOD →